MCK vs NEOG: fair value comparison
McKesson Corporation and Neogen Corporation · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, NEOG currently sits closer to the top of our discount ranking. NEOG carries the stronger momentum grade.
| MCK | NEOG | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $893.39 | $11.90 |
| 12-month range | $691.62–$990.95 | $5.64–$11.90 |
| Sector rank | #78 of 113 Healthcare | #75 of 113 Healthcare |
| Quality grade | F | F |
| Momentum grade | B | A |
| Leverage | Low | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Undervalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: MCK fair value analysis · NEOG fair value analysis